Haikyuu Legends is an exciting Roblox game inspired by the popular anime Haikyuu!!, bringing the intense world of volleyball to life. In the game, players can join different teams, train their ...

However, the asset faced a series of setbacks in 2024. The FDA on Friday approved AstraZeneca and Daiichi Sankyo’s Dato-DXd, to be known as Datroway, for patients with certain advanced breast ...

Robotics technology is advancing, but investors should be cautious; I rate Serve Robotics as a cautious sell until tangible progress is seen. SERV, spun off by Uber, aims to revolutionize urban ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab deruxtecan) has been approved in the United States for ...

A targeted cancer therapy from AstraZeneca’s alliance with Daiichi Sankyo is now FDA approved to treat certain cases of advanced breast cancer, giving the British pharmaceutical giant another ...

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a milestone in the company’s efforts to turn it into a widely used blockbuster.

The current price of Dai (DAI) is $0.999207, as of February 4, 2025. Over the last 24 hours, the price has moved by -0.11%, with a change of -0.05% in the past hour. For longer-term performance, the ...

A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first U.S. approval for a drug for ...

President Biden released a farewell letter Wednesday saying that "It has been the privilege of my life to serve this nation for over 50 years." "Today, we have the strongest economy in the world ...

Haikyu!! is now in the works on its second and anime feature film preparing to bring the anime franchise to an end, and there’s no way that the movie is going to be able to tackle everything ...

Daiichi Sankyo is turning to the German city of Heidelberg for help developing antibodies. The Japanese pharma giant is teaming up with independent research institute BioMed X to form a new ...